Evaluation of Ocular Surface Inflammatory Mediators Effected by Lotemax

Clinical trial NCT02322528 · COMPLETED

Trial details

NCT number: NCT02322528
Sponsor: University of Rochester
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Sjogren's Disease

Start date: 2014-04-01
Primary completion: 2015-08-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.